APOE and Alzheimer disease: For example, there is already a blood-based test for AD based on the Aβ42/40 ratio (measured by mass spectrometry), age and APOE-ε4 genotype [74], which is concordant with PET imaging scans in 94% of cases (see ref. [75]).